ONC-301

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameONC-301

Drug Alias NameONC-300 series (Oncoceutics)ONC-301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSignal transducer and activator of transcription 3 modulatorsNuclear factor NF-kappa-B complex modulatorsTumor protein p53 stimulants +[4]

TargetsNuclear factor NF-kappa-B complexSignal transducer and activator of transcription 3Tumor protein p53 +[4]

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOncoceutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOncoceutics Inc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A